Company profile for Amgen Inc

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manu...
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
One Amgen Center Drive, Thousand Oaks, CA91320-1799
Telephone
Telephone
+1 805-447-1000
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://firstwordpharma.com/story/7235870

FIRSTWORD PHARMA
28 Apr 2026

https://www.reuters.com/legal/litigation/fda-proposes-withdraw-amgens-rare-autoimmune-disease-drug-2026-04-28/

REUTERS
27 Apr 2026

https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2026-first-quarter-financial-results-302753310.html

PR NEWSWIRE
25 Apr 2026
David Reese To Retire From Amgen
David Reese To Retire From Amgen

23 Apr 2026

// ENDPOINTS

https://endpoints.news/david-reese-to-retire-from-amgen/

ENDPOINTS
23 Apr 2026

https://firstwordpharma.com/story/7204623

FIRSTWORD PHARMA
22 Apr 2026

https://www.fiercebiotech.com/biotech/boehringer-amgen-discard-early-immunology-candidates-due-lack-clinical-potential

FIERCE BIOTECH
14 Apr 2026

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact TeneoBio and get a quotation

TeneoBio is a supplier offers 11 products (APIs, Excipients or Intermediates).

Find INTRAVENOUS SOLUTION STABILIZER (IVSS) bulk with DMF offered by TeneoBio

Find AMG 191 CELL LINE DEVELOPMENT bulk with DMF offered by TeneoBio

Find AMG 282 DRUG SUBSTANCE bulk with DMF offered by TeneoBio

Find AMG 191 DRUG SUBSTANCE bulk with DMF offered by TeneoBio

Find AMG 157 (TEZEPELUMAB) PHASE 3 CMC AMENDMENT (DRUG SUBSTANCE AND DRUG PRODUCT) bulk with DMF offered by TeneoBio

Find AMG 191 DRUG PRODUCT bulk with DMF offered by TeneoBio

Find BULK PURIFIED MURINE MONOCLONAL ANTIBODY (ABX-CBL) TO BLAST CELLS bulk offered by TeneoBio

Find HUMAN MONOCLONAL ANTIBODY (ABX-EGF) TO EPIDERMAL GROWTH FACTOR RECEPTOR bulk offered by TeneoBio

Find HUMAN MONOCLONAL ANTIBODY (MDX-015)(SP2/0,- AG14 CELLS, MEDAREX) TO IL15 bulk offered by TeneoBio

Find Carfilzomib bulk offered by TeneoBio

Find Recombinant Human Growth Hormone bulk offered by TeneoBio

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty